COVID-19 cases are decreasing in all 50 states, Dr. Anthony Fauci said on Wednesday. Average daily new cases have dropped from 71,000 in April to 31,200 in the past week. (CNBC Weekly)

Iovance CEO Maria Fardis announced her resignation after the company experienced another regulatory delay for lifileucel, its cell-based therapy for cancer. Iovance said it will not seek Food and Drug Administration approval until more data is accumulated. (STAT)

Exscientia is collaborating with Bristol Myers Squibb on a deal to boost its artificial intelligence offerings around BMS’s drug pipeline. The deal will focus on small molecule therapeutic drugs in oncology and immunology. (Endpoints News)

Texas Gov. Greg Abbott has banned mask mandates in local governments and public schools. The order, similar to ones in effect in Florida and South Carolina, imposes fines of up to $1,000 on officials who institute mandates. (Politico)

Emergent BioSolutions said it may restart manufacturing Johnson & Johnson COVID-19 vaccine doses within a few days. Around 100 million J&J vaccine doses are on hold following a contamination issue at an Emergent plant in Baltimore. (The Hill)